Clinical trials
Terminated Non-alcoholic Fatty Liver Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 4 |
| Novartis Pharmaceuticals | 2 |
| Tobira Therapeutics, Inc. | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alnylam Pharmaceuticals | 1 |
| Antipodean Pharmaceuticals, Inc. | 1 |
| Axcella Health, Inc | 1 |
| Bristol-Myers Squibb | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 21 |
| Liver Cirrhosis | 4 |
| Fatty Liver | 3 |
| Fibrosis | 3 |
| Liver Diseases | 2 |
| Cardiovascular Diseases | 1 |
| Cholesterol Ester Storage Disease | 1 |
| Coronary Artery Disease | 1 |
| Coronary Disease | 1 |
| Digestive System Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.